Drug or drug abuse testing agent are a type of diagnostic tool used to detect the presence of drugs or drug components in an individual's body fluids. These tests typically use samples such as urine, saliva, blood, or hair to determine whether an individual has used or abused drugs by detecting specific drug metabolites or the drug itself in the sample. Such tests are widely used in medical, judicial, employment screening and rehabilitation settings.

The global Drug or Substance Abuse Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Drug or Substance Abuse Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Drug or Substance Abuse Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Drug or Substance Abuse Testing in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Drug or Substance Abuse Testing include Boto Bio, Meridian Bioscience, Abbott, BD, Dräger, LabCorp, Quest Diagnostics, Randox Testing Services and United States Drug Testing Laboratories Inc. (USDTL), etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Drug or Substance Abuse Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug or Substance Abuse Testing.

Report Scope

The Drug or Substance Abuse Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug or Substance Abuse Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug or Substance Abuse Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drug or Substance Abuse Testing Market Report

Report Metric	Details
Report Name	Drug or Substance Abuse Testing Market
Segment by Type	Urine Testing Saliva Testing Blood Testing Hair Testing
Segment by Application	Hospital Judicial Body Employment Screening Rehabilitation Center Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Boto Bio, Meridian Bioscience, Abbott, BD, Dräger, LabCorp, Quest Diagnostics, Randox Testing Services, United States Drug Testing Laboratories Inc. (USDTL), Thermo Fisher Scientific Inc, Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Clinical Reference Laboratory Inc., Cordant Health Solutions, Omega Laboratories Inc., Psychemedics Corporation, Precision Diagnostics, Siemens Healthineers
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug or Substance Abuse Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Drug or Substance Abuse Testing Market report?

Ans: The main players in the Drug or Substance Abuse Testing Market are Boto Bio, Meridian Bioscience, Abbott, BD, Dräger, LabCorp, Quest Diagnostics, Randox Testing Services, United States Drug Testing Laboratories Inc. (USDTL), Thermo Fisher Scientific Inc, Siemens Healthineers AG, F. Hoffmann-La Roche Ltd, Clinical Reference Laboratory Inc., Cordant Health Solutions, Omega Laboratories Inc., Psychemedics Corporation, Precision Diagnostics, Siemens Healthineers

What are the Application segmentation covered in the Drug or Substance Abuse Testing Market report?

Ans: The Applications covered in the Drug or Substance Abuse Testing Market report are Hospital, Judicial Body, Employment Screening, Rehabilitation Center, Others

What are the Type segmentation covered in the Drug or Substance Abuse Testing Market report?

Ans: The Types covered in the Drug or Substance Abuse Testing Market report are Urine Testing, Saliva Testing, Blood Testing, Hair Testing

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drug or Substance Abuse Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Urine Testing

1.2.3 Saliva Testing

1.2.4 Blood Testing

1.2.5 Hair Testing

1.3 Market by Application

1.3.1 Global Drug or Substance Abuse Testing Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Judicial Body

1.3.4 Employment Screening

1.3.5 Rehabilitation Center

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drug or Substance Abuse Testing Market Perspective (2019-2030)

2.2 Drug or Substance Abuse Testing Growth Trends by Region

2.2.1 Global Drug or Substance Abuse Testing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Drug or Substance Abuse Testing Historic Market Size by Region (2019-2024)

2.2.3 Drug or Substance Abuse Testing Forecasted Market Size by Region (2025-2030)

2.3 Drug or Substance Abuse Testing Market Dynamics

2.3.1 Drug or Substance Abuse Testing Industry Trends

2.3.2 Drug or Substance Abuse Testing Market Drivers

2.3.3 Drug or Substance Abuse Testing Market Challenges

2.3.4 Drug or Substance Abuse Testing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drug or Substance Abuse Testing Players by Revenue

3.1.1 Global Top Drug or Substance Abuse Testing Players by Revenue (2019-2024)

3.1.2 Global Drug or Substance Abuse Testing Revenue Market Share by Players (2019-2024)

3.2 Global Drug or Substance Abuse Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Drug or Substance Abuse Testing Revenue

3.4 Global Drug or Substance Abuse Testing Market Concentration Ratio

3.4.1 Global Drug or Substance Abuse Testing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drug or Substance Abuse Testing Revenue in 2023

3.5 Drug or Substance Abuse Testing Key Players Head office and Area Served

3.6 Key Players Drug or Substance Abuse Testing Product Solution and Service

3.7 Date of Enter into Drug or Substance Abuse Testing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Drug or Substance Abuse Testing Breakdown Data by Type

4.1 Global Drug or Substance Abuse Testing Historic Market Size by Type (2019-2024)

4.2 Global Drug or Substance Abuse Testing Forecasted Market Size by Type (2025-2030)

5 Drug or Substance Abuse Testing Breakdown Data by Application

5.1 Global Drug or Substance Abuse Testing Historic Market Size by Application (2019-2024)

5.2 Global Drug or Substance Abuse Testing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Drug or Substance Abuse Testing Market Size (2019-2030)

6.2 North America Drug or Substance Abuse Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Drug or Substance Abuse Testing Market Size by Country (2019-2024)

6.4 North America Drug or Substance Abuse Testing Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drug or Substance Abuse Testing Market Size (2019-2030)

7.2 Europe Drug or Substance Abuse Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Drug or Substance Abuse Testing Market Size by Country (2019-2024)

7.4 Europe Drug or Substance Abuse Testing Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drug or Substance Abuse Testing Market Size (2019-2030)

8.2 Asia-Pacific Drug or Substance Abuse Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Drug or Substance Abuse Testing Market Size by Region (2019-2024)

8.4 Asia-Pacific Drug or Substance Abuse Testing Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Drug or Substance Abuse Testing Market Size (2019-2030)

9.2 Latin America Drug or Substance Abuse Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Drug or Substance Abuse Testing Market Size by Country (2019-2024)

9.4 Latin America Drug or Substance Abuse Testing Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drug or Substance Abuse Testing Market Size (2019-2030)

10.2 Middle East & Africa Drug or Substance Abuse Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Drug or Substance Abuse Testing Market Size by Country (2019-2024)

10.4 Middle East & Africa Drug or Substance Abuse Testing Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Boto Bio

11.1.1 Boto Bio Company Detail

11.1.2 Boto Bio Business Overview

11.1.3 Boto Bio Drug or Substance Abuse Testing Introduction

11.1.4 Boto Bio Revenue in Drug or Substance Abuse Testing Business (2019-2024)

11.1.5 Boto Bio Recent Development

11.2 Meridian Bioscience

11.2.1 Meridian Bioscience Company Detail

11.2.2 Meridian Bioscience Business Overview

11.2.3 Meridian Bioscience Drug or Substance Abuse Testing Introduction

11.2.4 Meridian Bioscience Revenue in Drug or Substance Abuse Testing Business (2019-2024)

11.2.5 Meridian Bioscience Recent Development

11.3 Abbott

11.3.1 Abbott Company Detail

11.3.2 Abbott Business Overview

11.3.3 Abbott Drug or Substance Abuse Testing Introduction

11.3.4 Abbott Revenue in Drug or Substance Abuse Testing Business (2019-2024)

11.3.5 Abbott Recent Development

11.4 BD

11.4.1 BD Company Detail

11.4.2 BD Business Overview

11.4.3 BD Drug or Substance Abuse Testing Introduction

11.4.4 BD Revenue in Drug or Substance Abuse Testing Business (2019-2024)

11.4.5 BD Recent Development

11.5 Dräger

11.5.1 Dräger Company Detail

11.5.2 Dräger Business Overview

11.5.3 Dräger Drug or Substance Abuse Testing Introduction

11.5.4 Dräger Revenue in Drug or Substance Abuse Testing Business (2019-2024)

11.5.5 Dräger Recent Development

11.6 LabCorp

11.6.1 LabCorp Company Detail

11.6.2 LabCorp Business Overview

11.6.3 LabCorp Drug or Substance Abuse Testing Introduction

11.6.4 LabCorp Revenue in Drug or Substance Abuse Testing Business (2019-2024)

11.6.5 LabCorp Recent Development

11.7 Quest Diagnostics

11.7.1 Quest Diagnostics Company Detail

11.7.2 Quest Diagnostics Business Overview

11.7.3 Quest Diagnostics Drug or Substance Abuse Testing Introduction

11.7.4 Quest Diagnostics Revenue in Drug or Substance Abuse Testing Business (2019-2024)

11.7.5 Quest Diagnostics Recent Development

11.8 Randox Testing Services

11.8.1 Randox Testing Services Company Detail

11.8.2 Randox Testing Services Business Overview

11.8.3 Randox Testing Services Drug or Substance Abuse Testing Introduction

11.8.4 Randox Testing Services Revenue in Drug or Substance Abuse Testing Business (2019-2024)

11.8.5 Randox Testing Services Recent Development

11.9 United States Drug Testing Laboratories Inc. (USDTL)

11.9.1 United States Drug Testing Laboratories Inc. (USDTL) Company Detail

11.9.2 United States Drug Testing Laboratories Inc. (USDTL) Business Overview

11.9.3 United States Drug Testing Laboratories Inc. (USDTL) Drug or Substance Abuse Testing Introduction

11.9.4 United States Drug Testing Laboratories Inc. (USDTL) Revenue in Drug or Substance Abuse Testing Business (2019-2024)

11.9.5 United States Drug Testing Laboratories Inc. (USDTL) Recent Development

11.10 Thermo Fisher Scientific Inc

11.10.1 Thermo Fisher Scientific Inc Company Detail

11.10.2 Thermo Fisher Scientific Inc Business Overview

11.10.3 Thermo Fisher Scientific Inc Drug or Substance Abuse Testing Introduction

11.10.4 Thermo Fisher Scientific Inc Revenue in Drug or Substance Abuse Testing Business (2019-2024)

11.10.5 Thermo Fisher Scientific Inc Recent Development

11.11 Siemens Healthineers AG

11.11.1 Siemens Healthineers AG Company Detail

11.11.2 Siemens Healthineers AG Business Overview

11.11.3 Siemens Healthineers AG Drug or Substance Abuse Testing Introduction

11.11.4 Siemens Healthineers AG Revenue in Drug or Substance Abuse Testing Business (2019-2024)

11.11.5 Siemens Healthineers AG Recent Development

11.12 F. Hoffmann-La Roche Ltd

11.12.1 F. Hoffmann-La Roche Ltd Company Detail

11.12.2 F. Hoffmann-La Roche Ltd Business Overview

11.12.3 F. Hoffmann-La Roche Ltd Drug or Substance Abuse Testing Introduction

11.12.4 F. Hoffmann-La Roche Ltd Revenue in Drug or Substance Abuse Testing Business (2019-2024)

11.12.5 F. Hoffmann-La Roche Ltd Recent Development

11.13 Clinical Reference Laboratory Inc.

11.13.1 Clinical Reference Laboratory Inc. Company Detail

11.13.2 Clinical Reference Laboratory Inc. Business Overview

11.13.3 Clinical Reference Laboratory Inc. Drug or Substance Abuse Testing Introduction

11.13.4 Clinical Reference Laboratory Inc. Revenue in Drug or Substance Abuse Testing Business (2019-2024)

11.13.5 Clinical Reference Laboratory Inc. Recent Development

11.14 Cordant Health Solutions

11.14.1 Cordant Health Solutions Company Detail

11.14.2 Cordant Health Solutions Business Overview

11.14.3 Cordant Health Solutions Drug or Substance Abuse Testing Introduction

11.14.4 Cordant Health Solutions Revenue in Drug or Substance Abuse Testing Business (2019-2024)

11.14.5 Cordant Health Solutions Recent Development

11.15 Omega Laboratories Inc.

11.15.1 Omega Laboratories Inc. Company Detail

11.15.2 Omega Laboratories Inc. Business Overview

11.15.3 Omega Laboratories Inc. Drug or Substance Abuse Testing Introduction

11.15.4 Omega Laboratories Inc. Revenue in Drug or Substance Abuse Testing Business (2019-2024)

11.15.5 Omega Laboratories Inc. Recent Development

11.16 Psychemedics Corporation

11.16.1 Psychemedics Corporation Company Detail

11.16.2 Psychemedics Corporation Business Overview

11.16.3 Psychemedics Corporation Drug or Substance Abuse Testing Introduction

11.16.4 Psychemedics Corporation Revenue in Drug or Substance Abuse Testing Business (2019-2024)

11.16.5 Psychemedics Corporation Recent Development

11.17 Precision Diagnostics

11.17.1 Precision Diagnostics Company Detail

11.17.2 Precision Diagnostics Business Overview

11.17.3 Precision Diagnostics Drug or Substance Abuse Testing Introduction

11.17.4 Precision Diagnostics Revenue in Drug or Substance Abuse Testing Business (2019-2024)

11.17.5 Precision Diagnostics Recent Development

11.18 Siemens Healthineers

11.18.1 Siemens Healthineers Company Detail

11.18.2 Siemens Healthineers Business Overview

11.18.3 Siemens Healthineers Drug or Substance Abuse Testing Introduction

11.18.4 Siemens Healthineers Revenue in Drug or Substance Abuse Testing Business (2019-2024)

11.18.5 Siemens Healthineers Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Randox Testing Services

United States Drug Testing Laboratories Inc. (USDTL)

Thermo Fisher Scientific Inc

Siemens Healthineers AG

F Hoffmann La Roche Ltd

Clinical Reference Laboratory, Inc.

Cordant Health Solutions

Omega Laboratories，Inc

Psychemedics Corporation

Precision Diagnostics

Siemens Healthineers

List of Tables

Table 1. Global Drug or Substance Abuse Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Urine Testing

Table 3. Key Players of Saliva Testing

Table 4. Key Players of Blood Testing

Table 5. Key Players of Hair Testing

Table 6. Global Drug or Substance Abuse Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Drug or Substance Abuse Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Drug or Substance Abuse Testing Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Drug or Substance Abuse Testing Market Share by Region (2019-2024)

Table 10. Global Drug or Substance Abuse Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Drug or Substance Abuse Testing Market Share by Region (2025-2030)

Table 12. Drug or Substance Abuse Testing Market Trends

Table 13. Drug or Substance Abuse Testing Market Drivers

Table 14. Drug or Substance Abuse Testing Market Challenges

Table 15. Drug or Substance Abuse Testing Market Restraints

Table 16. Global Drug or Substance Abuse Testing Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Drug or Substance Abuse Testing Market Share by Players (2019-2024)

Table 18. Global Top Drug or Substance Abuse Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug or Substance Abuse Testing as of 2023)

Table 19. Ranking of Global Top Drug or Substance Abuse Testing Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Drug or Substance Abuse Testing Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Drug or Substance Abuse Testing Product Solution and Service

Table 23. Date of Enter into Drug or Substance Abuse Testing Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Drug or Substance Abuse Testing Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Drug or Substance Abuse Testing Revenue Market Share by Type (2019-2024)

Table 27. Global Drug or Substance Abuse Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Drug or Substance Abuse Testing Revenue Market Share by Type (2025-2030)

Table 29. Global Drug or Substance Abuse Testing Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Drug or Substance Abuse Testing Revenue Market Share by Application (2019-2024)

Table 31. Global Drug or Substance Abuse Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Drug or Substance Abuse Testing Revenue Market Share by Application (2025-2030)

Table 33. North America Drug or Substance Abuse Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Drug or Substance Abuse Testing Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Drug or Substance Abuse Testing Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Drug or Substance Abuse Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Drug or Substance Abuse Testing Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Drug or Substance Abuse Testing Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Drug or Substance Abuse Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Drug or Substance Abuse Testing Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Drug or Substance Abuse Testing Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Drug or Substance Abuse Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Drug or Substance Abuse Testing Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Drug or Substance Abuse Testing Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Drug or Substance Abuse Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Drug or Substance Abuse Testing Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Drug or Substance Abuse Testing Market Size by Country (2025-2030) & (US$ Million)

Table 48. Boto Bio Company Detail

Table 49. Boto Bio Business Overview

Table 50. Boto Bio Drug or Substance Abuse Testing Product

Table 51. Boto Bio Revenue in Drug or Substance Abuse Testing Business (2019-2024) & (US$ Million)

Table 52. Boto Bio Recent Development

Table 53. Meridian Bioscience Company Detail

Table 54. Meridian Bioscience Business Overview

Table 55. Meridian Bioscience Drug or Substance Abuse Testing Product

Table 56. Meridian Bioscience Revenue in Drug or Substance Abuse Testing Business (2019-2024) & (US$ Million)

Table 57. Meridian Bioscience Recent Development

Table 58. Abbott Company Detail

Table 59. Abbott Business Overview

Table 60. Abbott Drug or Substance Abuse Testing Product

Table 61. Abbott Revenue in Drug or Substance Abuse Testing Business (2019-2024) & (US$ Million)

Table 62. Abbott Recent Development

Table 63. BD Company Detail

Table 64. BD Business Overview

Table 65. BD Drug or Substance Abuse Testing Product

Table 66. BD Revenue in Drug or Substance Abuse Testing Business (2019-2024) & (US$ Million)

Table 67. BD Recent Development

Table 68. Dräger Company Detail

Table 69. Dräger Business Overview

Table 70. Dräger Drug or Substance Abuse Testing Product

Table 71. Dräger Revenue in Drug or Substance Abuse Testing Business (2019-2024) & (US$ Million)

Table 72. Dräger Recent Development

Table 73. LabCorp Company Detail

Table 74. LabCorp Business Overview

Table 75. LabCorp Drug or Substance Abuse Testing Product

Table 76. LabCorp Revenue in Drug or Substance Abuse Testing Business (2019-2024) & (US$ Million)

Table 77. LabCorp Recent Development

Table 78. Quest Diagnostics Company Detail

Table 79. Quest Diagnostics Business Overview

Table 80. Quest Diagnostics Drug or Substance Abuse Testing Product

Table 81. Quest Diagnostics Revenue in Drug or Substance Abuse Testing Business (2019-2024) & (US$ Million)

Table 82. Quest Diagnostics Recent Development

Table 83. Randox Testing Services Company Detail

Table 84. Randox Testing Services Business Overview

Table 85. Randox Testing Services Drug or Substance Abuse Testing Product

Table 86. Randox Testing Services Revenue in Drug or Substance Abuse Testing Business (2019-2024) & (US$ Million)

Table 87. Randox Testing Services Recent Development

Table 88. United States Drug Testing Laboratories Inc. (USDTL) Company Detail

Table 89. United States Drug Testing Laboratories Inc. (USDTL) Business Overview

Table 90. United States Drug Testing Laboratories Inc. (USDTL) Drug or Substance Abuse Testing Product

Table 91. United States Drug Testing Laboratories Inc. (USDTL) Revenue in Drug or Substance Abuse Testing Business (2019-2024) & (US$ Million)

Table 92. United States Drug Testing Laboratories Inc. (USDTL) Recent Development

Table 93. Thermo Fisher Scientific Inc Company Detail

Table 94. Thermo Fisher Scientific Inc Business Overview

Table 95. Thermo Fisher Scientific Inc Drug or Substance Abuse Testing Product

Table 96. Thermo Fisher Scientific Inc Revenue in Drug or Substance Abuse Testing Business (2019-2024) & (US$ Million)

Table 97. Thermo Fisher Scientific Inc Recent Development

Table 98. Siemens Healthineers AG Company Detail

Table 99. Siemens Healthineers AG Business Overview

Table 100. Siemens Healthineers AG Drug or Substance Abuse Testing Product

Table 101. Siemens Healthineers AG Revenue in Drug or Substance Abuse Testing Business (2019-2024) & (US$ Million)

Table 102. Siemens Healthineers AG Recent Development

Table 103. F. Hoffmann-La Roche Ltd Company Detail

Table 104. F. Hoffmann-La Roche Ltd Business Overview

Table 105. F. Hoffmann-La Roche Ltd Drug or Substance Abuse Testing Product

Table 106. F. Hoffmann-La Roche Ltd Revenue in Drug or Substance Abuse Testing Business (2019-2024) & (US$ Million)

Table 107. F. Hoffmann-La Roche Ltd Recent Development

Table 108. Clinical Reference Laboratory Inc. Company Detail

Table 109. Clinical Reference Laboratory Inc. Business Overview

Table 110. Clinical Reference Laboratory Inc. Drug or Substance Abuse Testing Product

Table 111. Clinical Reference Laboratory Inc. Revenue in Drug or Substance Abuse Testing Business (2019-2024) & (US$ Million)

Table 112. Clinical Reference Laboratory Inc. Recent Development

Table 113. Cordant Health Solutions Company Detail

Table 114. Cordant Health Solutions Business Overview

Table 115. Cordant Health Solutions Drug or Substance Abuse Testing Product

Table 116. Cordant Health Solutions Revenue in Drug or Substance Abuse Testing Business (2019-2024) & (US$ Million)

Table 117. Cordant Health Solutions Recent Development

Table 118. Omega Laboratories Inc. Company Detail

Table 119. Omega Laboratories Inc. Business Overview

Table 120. Omega Laboratories Inc. Drug or Substance Abuse Testing Product

Table 121. Omega Laboratories Inc. Revenue in Drug or Substance Abuse Testing Business (2019-2024) & (US$ Million)

Table 122. Omega Laboratories Inc. Recent Development

Table 123. Psychemedics Corporation Company Detail

Table 124. Psychemedics Corporation Business Overview

Table 125. Psychemedics Corporation Drug or Substance Abuse Testing Product

Table 126. Psychemedics Corporation Revenue in Drug or Substance Abuse Testing Business (2019-2024) & (US$ Million)

Table 127. Psychemedics Corporation Recent Development

Table 128. Precision Diagnostics Company Detail

Table 129. Precision Diagnostics Business Overview

Table 130. Precision Diagnostics Drug or Substance Abuse Testing Product

Table 131. Precision Diagnostics Revenue in Drug or Substance Abuse Testing Business (2019-2024) & (US$ Million)

Table 132. Precision Diagnostics Recent Development

Table 133. Siemens Healthineers Company Detail

Table 134. Siemens Healthineers Business Overview

Table 135. Siemens Healthineers Drug or Substance Abuse Testing Product

Table 136. Siemens Healthineers Revenue in Drug or Substance Abuse Testing Business (2019-2024) & (US$ Million)

Table 137. Siemens Healthineers Recent Development

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Drug or Substance Abuse Testing Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Drug or Substance Abuse Testing Market Share by Type: 2023 VS 2030

Figure 3. Urine Testing Features

Figure 4. Saliva Testing Features

Figure 5. Blood Testing Features

Figure 6. Hair Testing Features

Figure 7. Global Drug or Substance Abuse Testing Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Drug or Substance Abuse Testing Market Share by Application: 2023 VS 2030

Figure 9. Hospital Case Studies

Figure 10. Judicial Body Case Studies

Figure 11. Employment Screening Case Studies

Figure 12. Rehabilitation Center Case Studies

Figure 13. Others Case Studies

Figure 14. Drug or Substance Abuse Testing Report Years Considered

Figure 15. Global Drug or Substance Abuse Testing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Drug or Substance Abuse Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Drug or Substance Abuse Testing Market Share by Region: 2023 VS 2030

Figure 18. Global Drug or Substance Abuse Testing Market Share by Players in 2023

Figure 19. Global Top Drug or Substance Abuse Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug or Substance Abuse Testing as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Drug or Substance Abuse Testing Revenue in 2023

Figure 21. North America Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Drug or Substance Abuse Testing Market Share by Country (2019-2030)

Figure 23. United States Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Drug or Substance Abuse Testing Market Share by Country (2019-2030)

Figure 27. Germany Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Drug or Substance Abuse Testing Market Share by Region (2019-2030)

Figure 35. China Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Drug or Substance Abuse Testing Market Share by Country (2019-2030)

Figure 43. Mexico Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Drug or Substance Abuse Testing Market Share by Country (2019-2030)

Figure 47. Turkey Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Drug or Substance Abuse Testing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Boto Bio Revenue Growth Rate in Drug or Substance Abuse Testing Business (2019-2024)

Figure 50. Meridian Bioscience Revenue Growth Rate in Drug or Substance Abuse Testing Business (2019-2024)

Figure 51. Abbott Revenue Growth Rate in Drug or Substance Abuse Testing Business (2019-2024)

Figure 52. BD Revenue Growth Rate in Drug or Substance Abuse Testing Business (2019-2024)

Figure 53. Dräger Revenue Growth Rate in Drug or Substance Abuse Testing Business (2019-2024)

Figure 54. LabCorp Revenue Growth Rate in Drug or Substance Abuse Testing Business (2019-2024)

Figure 55. Quest Diagnostics Revenue Growth Rate in Drug or Substance Abuse Testing Business (2019-2024)

Figure 56. Randox Testing Services Revenue Growth Rate in Drug or Substance Abuse Testing Business (2019-2024)

Figure 57. United States Drug Testing Laboratories Inc. (USDTL) Revenue Growth Rate in Drug or Substance Abuse Testing Business (2019-2024)

Figure 58. Thermo Fisher Scientific Inc Revenue Growth Rate in Drug or Substance Abuse Testing Business (2019-2024)

Figure 59. Siemens Healthineers AG Revenue Growth Rate in Drug or Substance Abuse Testing Business (2019-2024)

Figure 60. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Drug or Substance Abuse Testing Business (2019-2024)

Figure 61. Clinical Reference Laboratory Inc. Revenue Growth Rate in Drug or Substance Abuse Testing Business (2019-2024)

Figure 62. Cordant Health Solutions Revenue Growth Rate in Drug or Substance Abuse Testing Business (2019-2024)

Figure 63. Omega Laboratories Inc. Revenue Growth Rate in Drug or Substance Abuse Testing Business (2019-2024)

Figure 64. Psychemedics Corporation Revenue Growth Rate in Drug or Substance Abuse Testing Business (2019-2024)

Figure 65. Precision Diagnostics Revenue Growth Rate in Drug or Substance Abuse Testing Business (2019-2024)

Figure 66. Siemens Healthineers Revenue Growth Rate in Drug or Substance Abuse Testing Business (2019-2024)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions